The FDA is requiring new boxed warnings on TNF-blockers regarding the risk of lymphoma and other malignancies in children and adolescents who have received the drugs.
Denosumab is a new human monoclonal antibody that suppresses osteoclast function and thus inhibits bone resorption.
WHO recommendations for antiviral use for H1N1 flu; antibiotic use trends for acute respiratory tract infection; denosumab clears FDA Expert Panel; FDA Actions.
A healthy 67-year-old man, Mr. C, comes to your office for his annual examination, which includes a check of his serum prostate specific antigen (PSA)...
Initiation of a respiratory therapist-driven protocol for assessment and management of risk for respiratory complications in the study hospital's neurosurgery step-down, trauma/surgery step-down, and trauma/surgery general units was followed by an increase in the number of patients receiving respiratory treatments, but decreases in ICU and hospital stays and overall hospital costs.
In January 2009, the publication of an updated vancomycin monitoring guideline gave clinicians a set of recommendations on: 1) timing of monitoring, 2) optimal trough concentration, 3) dosing to achieve optimal trough concentrations, 4) loading doses for complicated infections, 5) criteria for monitoring, and 6) frequency of monitoring.